Sesen Bio announced the appointment of Monica Forbes as its Chief Financial Officer, effective immediately. Ms. Forbes will succeed Richard F. Fitzgerald, who will be leaving the Company effective August 30, 2019. In addition, the Company has appointed Kirstin Anderson, Corporate Controller, as Principal Accounting Officer.

Ms. Forbes previously served as the Company's Vice President of Finance. Ms. Forbes has more than 20 years of financial leadership experience, including prior experience leading the finance and administrative functions of late- and commercial-stage public and private life science companies. Ms. Forbes will report to the Company's President and CEO, Dr. Thomas Cannell, and she will lead Sesen Bio's finance department.

Ms. Forbes holds a Bachelor of Science in Business Administration from San Diego State University. Ms. Anderson currently serves as the Company's Corporate Controller. Ms. Anderson has extensive accounting and audit experience across multiple industries and has been an integral part of the Company's accounting team for the last five years.

Ms. Anderson will report to Ms. Forbes and she will continue to lead Sesen Bio's accounting department and oversee the Company's SEC and SOX reporting and compliance.